Deregulation of Pin1 substrates has been implied in the onset of various diseases, i.e., cancer, neurodegenerative disorders and metabolic syndromes including type 2 diabetes (T2D) [2,3,4,10,11,12]. This evidence concerns the gene PIN1 and cancer.